The discovery may lead to better treatment and vaccines for meningitis and may save the lives of a huge selection of children. Bacterial meningitis in childhood is nearly exclusively due to the respiratory system pathogens Streptococcus pneumoniae, Neisseria meningitidis, and Haemophilus influenzae. The mechanism utilized by these lethal germs to break through the bloodstream mind barrier has, as yet, been unknown. Related StoriesDiabetic retinopathy therapy improvements: an interview with Richard Kirk, CEO of PolyphotonixDeaths from avoidable risk elements: an interview with Dr Ali Mokdad, IHMECharles Bonnet syndrome: an interview with Dr.About AstraZeneca AstraZeneca is a worldwide, innovation-powered biopharmaceutical business with a major concentrate on the discovery, development and commercialisation of prescription medications for gastrointestinal, cardiovascular, neuroscience, inflammation and respiratory, oncology and infectious disease. AstraZeneca operates in over 100 countries and its own innovative medicines are utilized by an incredible number of patients worldwide.. ChemGenex will abide by FDA on potential regulatory way to progress OMAPRO for CML ChemGenex Pharmaceuticals Limited announced today it offers agreed with the U.S.